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Background: The Functional Assessment of Cancer Therapy (FACT) is one of the most commonly used self-report
instruments for evaluation of health-related quality of life in oncology patients. However, cultural considerations
necessitate testing of the subscales in different populations. We sought to qualitatively and quantitatively
investigate the applicability and psychometric properties of the Chinese version of the FACT-Cervix (FACT-Cx) in
Chinese women with cervical cancer.
Methods: Ten personal interviews were conducted in order to explore patients’ opinions about the scale and its
items in depth. In addition the questionnaire was administered to 400 women with cervical cancer to test its
psychometric properties. Reliability was assessed using Cronbach’s alpha coefficient and item-subscale correlation
while validity was evaluated using factor analysis and known-group validity.
Results: Some items related to sex and the ability to give birth were questioned in the personal interviews, mostly
regarding their significance and acceptance in the Chinese cultural context. The Cronbach’s alphas of FACT-Cx and
the subscales were greater than 0.7, except for the cervical-cancer-specific subscale which was 0.57. Factor analysis
demonstrated that the FACT-G construct generally paralleled the original. There were significant differences in the
FACT-Cx and some subscales between those receiving and not receiving treatment and among the patients with
different performance status.
Conclusions: In general, psychometric properties of the Chinese version supported its use with cervical cancer
patients in Mainland China. Further work is needed to improve the psychometric adequacy of the
cervical-cancer-specific subscale and adjust it to cultural considerations.
Keywords: Health-related quality of life, FACT-Cx, FACT-G, Chinese version, Psychometric properties, Cervical cancerBackground
Cervical cancer is the second most common cancer
among women worldwide. About 83% of cases occur in
developing countries, such as China and India, repre-
senting 15% of women’s cancers [1]. Current Chinese
estimates indicate that cervical cancer is the 5th most
frequent cancer among women aged 15–44 years [1].
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reproduction in any medium, provided the ormeans that women with cervical cancer will probably
have a life expectancy of more than twenty years after
diagnosis and treatment. Having to live with cervical
cancer and the outcomes of the treatment, how the
women can reclaim or keep their quality of life are in-
creasingly becoming as important as how to prolong
survival. In addition to morbidity and the 5-year survival
rate, health-related quality of life (HRQOL) has been
regarded as a key outcome indicator in oncology.
According to Cella et al., HRQOL has two fundamen-
tal components: multidimensionality and subjectivity.
The multidimensionality of HRQOL refers to thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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for their lives, including physical, functional, emotional,
and social well-being. Subjectivity refers to the fact
that HRQOL can only be understood from the patient’s
perspective [2]. Based on this, Cella and his colleagues
developed an instrument to empirically measure HRQOL,
the Functional Assessment of Cancer Therapy (FACT).
To date the FACT is one of the most commonly used
self-reported instruments for evaluation of HRQOL in
oncology patients. The instrument system has been trans-
lated into over 60 languages, including Chinese, by the
organization that developed the FACT [3,4]. The FACT-
general (FACT-G) is the core scale of the instrument
system and consists of four dimensions measuring phys-
ical well-being (PWB), social/family well-being (SFWB),
emotional well-being (EWB), and functional well-being
(FWB). To evaluate precisely and responsively the
HRQOL of patients with a specific cancer, some
cancer-site-specific subscales have also been developed
to address specific concerns related to that particular
cancer, such as the lung-cancer-specific subscale, breast-
cancer-specific subscale, and cervical-cancer-specific sub-
scale (CCS). Assessing the HRQOL of patients with
cervical cancer requires a combination of the FACT-G
and CCS, which constitutes the full scale, the FACT-
Cervix (FACT-Cx).
The FACT-G and some cancer-site-specific subscales,
developed in western contexts and applied to popula-
tions in western countries, have demonstrated adequate
reliability, validity and sensitivity to change, and are
thus valid and reliable choice for HRQOL measurement
[3-7]. To date reliability and validity data for gynecolo-
gic cancer-specific scales are available only for the
FACT-Ovarian (FACT-O) and FACT-Vulva (FACT-V).
Cronbach’s alpha of the FACT-O was 0.92 and test-
retest reliability was 0.81[8]. Cronbach’s alpha of the
FACT-V was 0.92 [7]. To prove known-group valid-
ation, a significant difference was found in the FACT-V
and Vulva subscale among the subgroups with different
performance status and disease stages [7]. Similarly, the
total FACT-O and emotional well-being scores could
distinguish subgroups of patients with different per-
formance status, as well as patients under and not
under active treatment [8]. To the best of our know-
ledge there are no published studies on psychometric
tests of the FACT-Cx or CCS.
Despite these results, the validity and reliability of an
instrument, when applied to a population in a different
cultural context, may differ from those of the original.
Because there is agreement that HRQOL is substantially
influenced by culture, it is inappropriate to apply the
FACT, which was developed in a western cultural con-
text, directly to a Chinese population. This is particularly
so given some unique health-related philosophies inChinese culture. For example, in traditional Chinese
medicine, health is viewed as harmony between the
forces of Yin and Yang within and between the body and
its environment. Illness, by contrast, is viewed as an im-
balance or disequilibrium of these powerful forces. Simi-
larly a satisfying social life means being in harmony with
one’s social environment [9]. Through this means one
can acquire a good quality of life. Due to the different
cultural background, the cultural equivalence and psy-
chometric properties of the FACT-G and FACT-Cx
should first be evaluated.
Although the FACT has been applied to Chinese can-
cer patients, few studies have reported on its reliability
and validity, particularly those from Mainland China
[10]. The FACT-G was primarily tested for its psycho-
metric properties in cancer patients in Hong Kong. This
special Chinese administrative region previously under
colonial government by the United Kingdom is a blend
of western and Chinese cultures. It was concluded that
although more work was needed to increase its ad-
equacy, the translated scale could reasonably be used for
Chinese populations in clinical settings [11]. Later Wan
et al. evaluated the FACT-G in 552 cancer patients in
Mainland China. Their study demonstrated acceptable
validity and reliability [12]. However, few studies have
evaluated the site-specific subscale together with the
FACT-G as applied in a Mainland Chinese context. To
date we found that only the FACT-Lung and FACT-
Breast were evaluated for psychometric properties in
patients with lung and breast cancer in Mainland China
[13,14]. In summary, while the FACT-Cx has been
translated into Chinese by the FACT development
organization, no investigation of its psychometric prop-
erties has to our knowledge been carried out in Main-
land China.
The purpose of this study was to qualitatively and
quantitatively investigate the applicability, validity and
reliability of the Chinese version of the FACT-Cx in
women with cervical cancer in Mainland China.Methods
Design
The study combined quantitative and qualitative meth-
ods in order to gain insight into the suitability of the
Chinese version of the FACT-Cx for use with women
with cervical cancer in Mainland China. We used a sur-
vey to test the psychometric properties of the scale.
However, to ensure applicability we also carried out per-
sonal interviews in a smaller sample. This allowed us to
discover whether participants found any of the items dif-
ficult to respond to, which could lead to a large internal
drop-out. Thus face-to-face personal interviews comple-
mented the quantitative method and provided detailed
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ficult to respond to.Subjects
The subjects were recruited in two specialized university
hospitals in Shanghai, China. Their reputation regarding
gynecological cancer treatment attracted patients with
cervical cancer not only from Shanghai but from all over
China. Thus the cervical cancer population in the two
hospitals presented a rich sample pool for the study.
Both ethics committees of the two hospitals approved
the study (approval numbers 2008–40 and 090472–12).
Patients diagnosed with cervical cancer were considered
potential subjects. The inclusion criteria were: (1) patho-
logically diagnosed with cervical cancer; (2) Chinese resi-
dent with full knowledge of the Chinese language; (3) not
diagnosed with any other type of cancer; (4) not diagnosed
with a major medical or psychiatric condition. Informed
consent was obtained from each potential subject prior to
data collection.Measure to be tested: the Chinese version of the FACT-Cx
FACT-Cx comprises FACT-G and CCS. The FACT-G
has four domains, seven items measuring PWB, seven
items measuring SFWB, six items measuring EWB, and
seven items measuring FWB. The CCS, also called “add-
itional concerns”, contains 15 additional items specific-
ally related to cervical cancer and its treatment sequelae.
The FACT-Cx can be self-administered or used in an
interview format. Patients are asked to rate from 0 to 4
how they feel today and have felt during the preceding 7
days. There are some reverse-stated items, which have
to be negatively scored. The score for each domain is
obtained by adding up all the item scores within that do-
main. The FACT-G score is the summed score for the
four domains. The FACT-Cx score is the total score for
the FACT-G plus CCS (Table 1). A higher score indi-
cates a better HRQOL. The possible range of scores is 0
to 168 [15].Table 1 Scoring method and Cronbach’s alpha





Physical wellbeing (PWB) 7 0-28 0.736
Social/family wellbeing (SFWB) 7 0-28 0.817
Emotional wellbeing (EWB) 6 0-24 0.759
Functional wellbeing (FWB) 7 0-28 0.807
FACT-G (PWB+SFWB+EWB+FWB) 27 0-108 0.872
Cervical–cancer-specific subscale (CCS) 15 0-60 0.570
FACT-Cx (FACT-Cx + CCS) 42 0-168 0.876The Chinese version was provided by the Center on
Outcome, Research and Education (CORE), Evanston
Northwestern Healthcare, Northwestern University,
which is mainly involved in the development, translation
and linguistic validation of FACT measures. To our




Consecutive sampling was used for quantitative data col-
lection. Four hundred respondents for the questionnaire
survey were recruited simultaneously from outpatient
and inpatient settings. There was an on-site coordinator
in each setting who informed the investigator when
there were patients who met the inclusion criteria. The
investigator approached the patients seeking informed
consent. Thereafter the patients were asked to complete
the Chinese version of the FACT-Cx in the presence of
the investigator. Once a subject had finished the ques-
tionnaire, the investigator checked that it was complete
and marked those items that the subject had not wanted
to respond to.
Qualitative data collection
Consecutive sampling was also used for qualitative data
collection. The first author chose the ten subjects and
carried out all the personal interviews. Patients from the
sample for the questionnaire survey were approached
and asked to participate in the interviews if they were
experienced as open, talkative, and eloquent by the first
author. Oral explanation of the study was provided and
confidentiality was assured. It was also stressed that par-
ticipation was voluntary and that they could withdraw
from the study at any time without giving any reason.
Because the first two patients both did not agree to tape
recording this was abandoned. Once consent was given,
a patient was asked to complete the questionnaire by
herself. Once completed it was checked by the inter-
viewer for missing data or other problems. The inter-
viewer then asked about each FACT-Cx item as follows:
whether it was clear and easy to understand; whether
there was a better way to express the idea or if there
were any related comments; whether there were any
items that were difficult to understand, irrelevant or
offensive; whether the patient had any other comments
to make in general. The patients were encouraged to de-
scribe any reaction or reflection in relation to each item
and further questions were asked if needed to obtain fur-
ther clarification about their views. Finally the notes
were shown to the patient for validation. Each interview
took around 1.5 to 2.5 hours. The presence of family
members during the interviews was discouraged to avoid
any influence on patients’ responses.
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ance status and demographic and socio-economic char-
acteristics. Performance status was divided into five
categories: normal activity, without symptoms; some
symptoms but not requiring bed rest during daytime; re-
quiring bed rest for less than 50% of daytime; requiring
bed rest for more than 50% of daytime; and unable to
get out of bed. All the subjects were asked to fill in the
form. Their disease characteristics were obtained from
their medical records, such as pathological diagnosis,
disease stage, and treatment modalities.Data analysis
The item-subscale correlation and Cronbach’s alpha co-
efficient were calculated to evaluate internal consist-
ency. Higher than 0.2 for the item-subscale correlation
and higher than 0.7 for the alpha coefficient were
regarded as acceptable [17,18]. Validity was assessed in
terms of construct validity and known-group validity.
Based on the operational definition of HRQOL, the four
subscales of the FACT-G were supposed to be interre-
lated. Thus an oblique rotation method for factor ana-
lysis was performed in this study, forcing a four-factor
solution to replicate the original work [3,6,19]. Each
item was expected to load in its original domain with
the largest factor loading. The Eigenvalues of the four
factors should be greater than 1 [19]. To evaluate
known-group validity, the mean scores of the FACT-Cx,
FACT-G and the subscales were compared with Stu-
dent’s t-test between the two groups under active treat-
ment and not under active treatment. The Kruskal-
Wallis test was used to compare the scores of the
FACT-Cx, FACT-G and the subscales among the five
groups categorized by the levels of performance status,
as well as among the four groups at varying disease
stages. This was because some groups were too small
and not equal in size to the other groups [20]. It was
hypothesized that the HRQOL questionnaire could dif-
ferentiate the patients under active treatment from
those who were not, as well as patients at various stages
or with varying levels of performance status. The
known-group validity was regarded as acceptable if
there were statistically significant differences in
HRQOL. To compare the responses to item C6 (I have
concerns about my ability to have children) between
the women with and without children, the Mann–
Whitney U-test was employed because the shape of
the sample distributions was not normal [21]. Statis-
tical analyses were performed using the Statistical
Package for Social Science 13.0 (SPSS13.0). All-
available approach was defaulted to manage the miss-
ing data, which means using all valid values for each
variable and only ignoring the missing values [22].Results
Personal interviews
The ten patients ranged from 30 to 47 years of age. Eight
were diagnosed with squamous cell carcinoma and two
with adenocarcinoma. Cancer stage varied from Ib to
IIa. Six patients were under active treatment and all of
them had borne a child before being diagnosed with cer-
vical cancer (Table 2).
All the subjects filled in the questionnaire independ-
ently in 10–20 minutes. No item was regarded as diffi-
cult to understand. One patient mentioned some other
things that should be included however these were
already in the questionnaire. Five items were questioned
and regarded as inappropriate, one from the SFWB sub-
scale, item S7 “I am satisfied with my sex life”; the others
all from the CCS, item C4 “I feel sexually attractive”;
item C5 “My vagina feels too narrow or short”; item C6
“I have concerns about my ability to have children”; and
item C8 “I am interested in sex” (Table 3).
Survey
The 400 subjects ranged in age from 19 to 68 years with
a mean age of 42.63 years; 86.0% of them were diag-
nosed with squamous cell carcinoma; Time since diag-
nosis ranged from 0 to 79 months with a mean of 5.51;
61.3% were in stage I; 61% were under active treatment
and 93.3% had borne a child before being diagnosed
with cervical cancer. Although 74.8% of the subjects
rated their family income lower than 5000 RMB per
month (One RMB is roughly equivalent to 0.15 US dol-
lars), 76.0% perceived their family financial status as
average, only 4.5% rated themselves as poor. Of the
patients 56.8% had to pay more than half their medical
expenses themselves and 20.8% perceived their financial
burden as “extreme” (Table 2).
As in the personal interviews, some patients declined
to answer the sex-related items. For S7 (I am satisfied
with my sex life), the non-response rate was as high as
24.25% (Table 3).
All the items in the FACT-G had item-subscale corre-
lations higher than 0.50 except for item E2 which was
0.34. In the CCS subscale, the item-subscale correlations
ranged from 0.18 to 0.49. Item C6 (I have concerns
about my ability to have children) alone was lower than
0.2. The Cronbach’s alpha coefficients of the FACT-Cx
and all the subscales were higher than 0.7 except for the
CCS subscale which was 0.57 (Table 1). Dropping item
C6 slightly increased the alpha coefficient to 0.58 for the
remaining 14 items in the CCS. However dropping more
items could not elevate the alpha coefficients further.
In factor analysis, the forced four-factor solution
accounted for almost half of the explained variance
(49.84%). The Eigenvalues of all the four principal com-
ponents were greater than 1. The first principal












Primary school 1 10 87 21.8
Secondary school 2 20 144 36.0
High school 4 40 111 27.8
College level or above 3 30 56 14.0
Missing 2 0.5
Marital status
Married 9 90 378 94.5
Unmarried 3 0.8
widowed 3 0.8
Divorced 1 10 15 3.8
Separated 1 0.3
Family income (RMB/month)
<2000 2 20 121 30.3
2000~5000 6 60 178 44.5
5001~8000 39 9.8
8001~10000 1 10 20 5.0




Average 2 20 304 76.0
Poor 8 80 78 19.5
Type of medical payment
full insurance 34 8.5
=>50% insurance 6 60 132 33.0
>50% self-paid 1 10 108 27.0
Fully self-paid 3 30 119 29.8
Missing 7 1.8
Pathological diagnosis
squamous cell carcinoma 8 80 344 86.0





I 8 80 245 61.3
II 2 20 86 21.5
III 3 0.8
Missing 15 3.8
Table 2 Characteristics of the subjects (Continued)
Treatment modality
No treatment 4 40 156 39.0
Surgery 4 40 164 41.0
Chemotherapy 41 10.3
Radiotherapy 6 1.5
Surgery and chemotherapy 2 20 23 5.8








6 60 189 47.3
Some symptoms,
but does not require
bed rest during daytime
4 40 81 20.3
Requires bed rest for
less than 50% of daytime
28 7.0
Requires bed rest for
more than 50% of daytime
90 22.5
Unable to get out of bed 8 2.0
Missing 4 1.1
Having children or not
Yes 10 100 373 93.3
Not 25 6.2
Missing 2 .5
Abbreviation: RMB, Ren-Ming-Bi (Chinese dollar. One RMB roughly equal to .15
US dollars).
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nent to SFWB; the third to PWB, and the fourth to
FWB. However, item P6 in PWB cross-loaded on the
first and third principal components. Item E2 in EWB
cross-loaded strongly on the second, third and forth
principal components rather than on the first principal
component (Table 4).
There was a significant difference in the PWB, CCS,
FACT-G, and FACT-Cx between the two groups under
treatment and not under treatment (Table 5). There was
also a significant difference in the PWB, FWB, CCS,
FACT-G and FACT-Cx among the five groups with dif-
ferent levels of performance status (Table 6). Among the
four groups categorized by disease stage, no statistically
significant difference was found in the FACT-Cx and the
subscales, except for SFWB (Table 7).
Twenty-five women had not borne a child. Comparing
the scores for item C6 (I have concerns about my ability
to have children) between the women with a child and
those without, using Mann–Whitney U-test, the value of
Z was −4.248 and p-value was lower than 0.001, suggest-
ing that those who had not given birth had concerns.
Table 3 Subjects’ item responses in the qualitative and quantitative investigation
Item Personal interviews (n=10) Questionnaire survey (n=400)
Comments Number of non-response (%)
In the social/family wellbeing subscale (SFWB):
S7: I am satisfied with my sex life Too private to answer (n=1) 97 (24.25)
In the cervical-cancer-specific subscale (CCS):
C3: I am afraid to have sex No comment 15 (3.75)
C4: I feel sexually attractive Too private to answer (n=1) 25 (6.26)
C5: My vagina feels too narrow or short It seems to be a question for sexual partner (n=1) 18 (4.50)
C6: I have concerns about my
ability to have children
Little significant due to uterus removal (n=1); 21 (5.25)
Have a child already, so the question is of little significance (n=2);
The question is conditional on having or not having a child (n=1).
C8: I am interested in sex Too private to answer (n=2) 23 (5.75)
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This study is to the best of our knowledge the first to as-
sess the psychometric properties of the Chinese version
of the FACT-Cx in Mainland China. It integrated quanti-
tative and qualitative methods to place the statistical
results in context, with the qualitative data adding depth
and meaning to the quantitative results [23].
The personal interviews demonstrate that the Chinese
version of the FACT-Cx, in terms of its understandabil-
ity and administration, has acceptable feasibility. They
however provide some insights into the distinct perspec-
tives of Chinese women with cervical cancer concerning
their reproductive ability. They were much less con-
cerned about the loss of their reproductive ability than
subjects in similar studies in the western world. The rea-
son may be the “One Child Policy”, which has long been
in force in Mainland China limiting Han ethnic Chinese
couples to one child only. Most women have already
borne a child before being diagnosed with cervical can-
cer, and thereby regardless of whether or not they were
able to reproduce, they could not have another baby.
Given these circumstances, it makes sense that item C6
“I have concerns about my ability to have children”
appeared to have little significance for women in Main-
land China, even though treatment for cervical cancer
deprived their ability to have children. This differs from
the views about loss of childbearing ability in western
women with cervical cancer. Schover summarized the
literature about the effects of cervical cancer treatment
on sexuality and found that reproductive concerns were
a major issue for survivors of cervical cancer. Their
mental suffering arising from the loss of childbearing is
substantial [24-26]. However, it is worth noting that all
the ten women interviewed were one-child mother. In
the following quantitative investigation, there was a sig-
nificant difference in the score for the item related to re-
productive ability between those with a child and those
without. This indicated that the women without a childwere concerned about their reproductive ability. Thus
the findings apparently reflect a political decision and
might change if the policy were changed.
The interviews also revealed that Chinese women tend
to regard sexual issues as private. This was confirmed by
the relatively low item response rates for sex-related
items in the quantitative study. Chinese culture retains
conservative values concerning sexual issues and is gen-
erally less sexually outspoken than western culture.
Taoism, one major Chinese philosophy, suggests the
regulation of sexual activities to preserve one’s health
[27]. A manifestation of this is the Chinese cultural be-
lief that intimacy between close partners is more inde-
pendent of sexual relations than it is in the West [11].
Moreover, influenced by Chinese tradition in the long
term, active sex is regarded by many people as the rea-
son for the occurrence and progression of gynecological
cancer [28]. Thus patients are reluctant to talk to stran-
gers about the “sensitive” topics such as sexuality. This
may be the main underlying factor affecting their
responses to sex-related items [11]. Nevertheless, a cav-
eat for clinical professionals providing healthcare for cer-
vical cancer survivors in a Chinese context is in order.
The hesitation to openly discuss the sexual problems
does not mean that such problems are not experienced
or that they may not be detrimental to women’s
HRQOL. The findings from Zeng et al’s study showed
that some Chinese survivors of cervical cancer defined
the importance of their sex life and the harmony of the
sexual relationship with their husband as one of the
major indicators of their quality of life [29]. In a study
undertaken in Korea, anxiety about sexual performance
was prevalent in cervical cancer survivors and dyspar-
eunia was a major and distressing problem for women
who received radiotherapy for cervical cancer [30]. Al-
though Chinese culture obscures understanding of
patients’ true sexual concerns, professionals are expected
to clarify the problems in this respect and find effective
Table 4 Items in each original subscale of the FACT-G in relation to factor structure and loadings of this study
Factor structure originally Component in this analysis Com.
1 2 3 4
Physical wellbeing (PWB):
P1: I have a lack of energy -.042 -.014 .551a -.091 .321
P2: I have nausea -.011 .029 .611 a .007 .371
P3: Because of my physical condition,
I have trouble meeting the needs of my family
.173 .073 .520 a -.117 .422
P4: I have pain .010 .067 .696 a .014 .493
P5: I am bothered by the side effects of treatment .264 .225 .402 a .051 .337
P6: I feel ill .476 a -.132 .302 -.142 .468
P7: I am forced to spend time in bed .010 -.047 .755 a -.064 .598
Social/family wellbeing (SFWB):
S1: I feel close to my friends -.108 .665 a .029 -.082 .471
S2: I get emotional support from my family .136 .767 a .054 .148 .580
S3: I get support from my friends -.117 .663 a .027 -.130 .493
S4: My family has accepted my illness -.093 .704 a -.012 -.007 .489
S5: I am satisfied with family communication about my illness -.040 .814 a -.023 .073 .627
S6: I feel close to my partner (or the person who is my main support) .138 .745 a -.048 .018 .587
S7: I am satisfied with my sex life -.019 .500 a .125 -.074 .300
Emotional wellbeing (EWB):
E1: I feel sad .619 a .073 .123 -.141 .555
E2: I am satisfied with how I am coping with my illness .038 .285 a -.277 -.238 .223
E3: I am losing hope in the fight against my illness .561 a .137 .047 .018 .361
E4: I feel nervous .827 a -.070 -.090 -.083 .696
E5: I worry about dying .852 a -.109 -.030 -.069 .745
E6: I worry that my condition will get worse .912 a -.101 -.014 .017 .801
Functional wellbeing (FWB):
F1: I am able to work (include house-work) -.182 -.072 .312 -.721 a .601
F2: My work (include house.work) is fulfilling -.008 -.066 -.071 -.804 a .594
F3: I am able to enjoy life .115 .034 -.102 -.759 a .641
F4: I have accepted my illness .145 .234 -.108 -.479 a .413
F5: I am sleeping well .096 .017 .105 -.389 a .229
F6: I am enjoying the things I usually do for fun .155 .007 .097 -.562 a .451
F7: I am content with the quality of my life right now .131 .153 .078 -.626 a .593
Eigenvalues 6.552 3.401 1.948 1.556
Variance contribution (%) 49.842 24.268 12.597 7.215 5.762
a The greatest factor loading for each item.
Abbreviation: Com, Communalities.
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ceptability of the sex-related items within the subscale of
the CCS is an important and challenging task. Add-
itional work is required.
Although the personal interviews revealed some im-
portant clues about the properties of the instrument,
given that the intent is to use this translation for meas-
urement purposes, the psychometric tests provide evi-
dence of the reliability and validity of the scale.Essentially, internal consistency represents the average
of the correlations among all the items in the measure.
This implies that each item should correlate with the
subscale score [17]. The item-subscale correlations for
all the items were acceptable except for item C6 (I have
concerns about my ability to have children) in the CCS.
Consistent with the results from the personal interviews,
the item-subscale correlation for item C6 was lower than
0.2. It did not meet the acceptability requirement and
Table 5 Comparison of HRQOL between the groups receiving and not receiving treatment
Receiving treatment (n=242) Not receiving treatment (n=156) t p-value
Mean (SD) Mean(SD)
Physical wellbeing (PWB) 20.03(5.05) 23.23(3.65) −7.156 <.001**
Social/family wellbeing (SFWB) 22.11(5.34) 23.19(4.34) −0.772 .440
Emotional wellbeing (EWB) 17.67(4.92) 17.48(5.11) 0.364 .716
Functional wellbeing (FWB) 16.94(5.98) 17.02(6.22) −0.117 .907
FACT-G 76.18(15.79) 80.40(13.92) −2.139 .033*
Cervical-cancer-specific subscale (CCS) 41.95(6.55) 43.50(5.57) −2.168 .031*
FACT-Cx 117.46(20.31) 124.47(17.44) −2.663 .008**
* P<.05; ** P<.01.
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in a Chinese context [16,17]. The alpha coefficient of the
CCS without item C6 was actually a little higher than
that of the CCS. However, 93.3% of the subjects already
had children. They tended to have the same, or a similar,
response to the item as in the personal interviews. There
is a possible source of bias for the item, contributing to
the low item-subscale correlation of item C6. Further in-
vestigation in a more representative sample including a
sufficient number of childless women with cervical can-
cer is required to clarify the item’s adequacy in a Chinese
cultural context.
The Cronbach’s alpha coefficient of the FACT-Cx was
0.88 and all the subscales were higher than 0.70 except
for the CCS which was 0.57. This indicated that the
FACT-Cx had good reliability whereas the CCS’s reliabil-
ity was marginal. Likewise, other studies also found a
relatively low Cronbach’s alpha coefficient for some
cancer-site-specific subscales, such as the lung-cancer-
specific subscale and breast-cancer-specific subscale
[5,13,14]. The lung-cancer-specific subscale was 0.68 in
a western cultural context in Cella et al’s investigation
[5] and 0.56 in a Chinese cultural context in Wan et al’s
study [13]. The breast-cancer-specific subscale was only
0.59 in a Chinese sample[14]. One possible explanation
for this may be that these subscales usually cover diverse
aspects related to treatment, complications, side effects,
and particular concerns, with the result that the itemsTable 6 Comparison of HRQOL among the groups by perform
Performance Status 0 (n=189) 1 (n=81) 2 (n=28)
Mean (SD) Mean (SD) Mean (SD
PWB 23.47(3.58) 20.68(4.30) 20.00(4.02
SFWB 19.70(4.64) 20.37(4.19) 19.89(4.61
EWB 18.07(4.57) 16.62(5.28) 17.64(5.45
FWB 18.23(6.39) 16.64(5.24) 15.50(4.00
FACT-G 79.51(13.25) 74.30(14.22) 73.04(13.1
CCS 43.53(5.69) 40.99(6.64) 42.56(5.77
FACT-Cx 122.36(17.13) 115.14(18.88) 114.60(15.6
* P<.05; ** P<.01.are not really related [13]. The relative homogeneity of
the sample probably also accounted for the low alpha
value. Reliability involves the ratio of variability among
subjects to total variability, thus conducting a test study
on an extremely heterogeneous sample ensures good re-
liability of an instrument [17]. Compared to the whole
population of women with cervical cancer, the sample in
this study was perhaps too homogeneous. Because the
subjects were recruited from two top-grade university
hospitals located in a big city in China, they tended to
have higher education and higher income than the aver-
age. Furthermore the majority of the subjects were in an
early stage of their disease. If more patients in the late
stages were included and their financial status varied
considerably, the internal consistency would probably
improve.
The results of the factor analysis paralleled the original
with two minor discrepancies. Item P6 “I feel ill” loaded
on the EWB factor rather than on the PWB factor. From
Chinese people’s perspectives, “someone feels ill” does
not mean “someone is really ill” and rather reflects his/
her feelings for his/her body. The item is thus highly
relevant to EWB, an intuitively more attractive location
for this item. Item E2 “I am satisfied with how I am cop-
ing with my illness” in the EWB subscale cross-loaded
on the PWB, SFWB and FWB factors at similar factor
loadings. The explanation may lie in that the extent to
which a patient is satisfied with her coping with diseaseance status
3 (n=90) 4 (n=8) Chi-Square P value
) Mean (SD) Mean (SD)
) 17.11(5.11) 16.63(1.89) 110.741 <.001**
) 20.71(3.80) 19.25(4.89) 3.487 .480
) 17.44(5.09) 15.88(6.92) 4.620 .329
) 15.32(5.78) 11.38(6.80) 22.738 <.001**
0) 70.56(14.45) 63.13(14.89) 30.392 <.001**
) 41.77(6.84) 37.75(5.06) 12.535 .014*
5) 111.37(19.18) 100.88(18.87) 23.927 <.001**
Table 7 Comparison of HRQOL among the groups by stage
Stage 0 (n=51) I (n=245) II (n=86) III (n=3) Chi-Square P value
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
PWB 22.47(4.40) 20.86(5.01) 21.19(4.56) 20.33(2.31) 5.329 .149
SFWB 18.78(5.07) 19.82(4.44) 21.48(3.46) 19.33(6.43) 14.588 .002**
EWB 17.88(4.43) 17.83(4.85) 16.93(5.56) 20.67(3.21) 2.643 .450
FWB 18.63(5.70) 16.60(6.32) 17.34(5.51) 12.67(3.79) 7.234 .065
FACT-G 78.09(13.55) 75.06(14.84) 76.82(13.77) 73.00(1.73) 2.530 .470
CCS 44.05(5.92) 42.37(6.53) 42.22(5.53) 36.00(13.45) 3.585 .310
FACT-Cx 121.55(17.22) 116.53(19.78) 118.55(16.99) 109.00(14.73) 2.798 .424
** P<.01.
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as reflected in physical, social/family and functional well-
being. If things go well in these three areas, the patient
interprets it as the result of her successful coping and
thereby feels satisfied.
A reliable and valid HRQOL instrument should be
sensitive to clinical subgroups’ differences. It was
hypothesized that the HRQOL questionnaire had the
ability to differentiate between patients under active
treatment and those who were not, patients with differ-
ent levels of performance status, and patients at different
stages of their disease. As anticipated, there was a sig-
nificant difference in patients’ FACT-Cx scores between
treatment and non-treatment groups, as well as in
FACT-G, PWB and CCS scores. Furthermore, significant
differences in the PWB, FWB, CCS, FACT-G and FACT-
Cx, were also found among the five groups categorized
by level of performance status. The results show that
known-group validity is good in Chinese cultural con-
text, consistent with the results in US women with cer-
vical cancer [15]. That implies that the FACT-Cx has
adequate known-group validity cross-culturally. How-
ever, there was no significant difference in HRQOL
among the patients at different cancer stages, except for
EWB. One possible explanation, as mentioned above is
that the sample was too homogeneous. The majority of
subjects were at an early stage of their cancer and the
differences in HRQOL among the groups at different
stages were too small to be detected.
There are some limitations which need to be recog-
nized. First of all, it is the representativeness of the sam-
ple. Provided that all the subjects were recruited from
the two top-level hospitals in a big city, they tended to
be better off in terms of socio-economic aspects. In
addition the majority of the subjects were in an early
stage of their disease. This may limit the generalizability
of the findings. Secondly, the presence of the investiga-
tor may have improved the quality of responses, however
it may also have influenced the patients’ choices, espe-
cially for some sensitive items, such as the sex-relateditems. There may also have been an effect from social
desirability.
Conclusion
From the viewpoint of Chinese women with cervical
cancer, the Chinese version of the FACT-Cx covered the
major areas that were perceived as important. It was
regarded as easy to understand and administer. In gen-
eral, its internal consistency was acceptable. The Chinese
version of the FACT-G demonstrates a factor structure
comparable with the original, and the FACT-Cx and
CCS showed acceptable known-group validity. Thus the
FACT-Cx appears suitable to serve as an instrument for
measuring HRQOL in women with cervical cancer in
Mainland China. However, some limitations existed
in the CCS subscale. Firstly, the internal consistency
was marginal with one item that of loss of reproductive
ability having low item-subscale correlation. The qual-
itative and quantitative findings both suggest further
research to improve the understanding and measure-
ment of Chinese survivors’ concerns about loss of repro-
ductive ability. In addition, due to Chinese people’s
view of sex as a taboo topic, improving the response rate
for sex-related items in the CCS is another challenge
for Chinese investigators. The homogeneity and under-
representativeness of our sample undermined the reliabil-
ity and generalization of the findings. Further investigation
of the scale’s psychometric properties is recommended in
more heterogeneous samples.
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